Insights
Farient’s latest executive compensation leadership
Through its research, blogs, and commentary, Farient is driving the conversation on executive compensation and governance issues.
May 24, 2021
Fintech Zoom – Novavax Stock – INSIGHT Novavax bosses cash out for $46 mln with COVID-19 vaccine trials still under way
Novavax Stock- INSIGHT Novavax bosses cash out for $46 mln with COVID-19 vaccine trials still under way
Read MoreMay 24, 2021
Agenda – What to Know Before Joining a SPAC Board
Directors can receive a hefty windfall for taking a seat on a Special-Purpose Acquisition Company (SPAC) board, and such appointments present new and interesting challenges for a seasoned director. However, sources say it’s important to weigh the attendant risks before getting involved.
Read MoreMay 24, 2021
Corporate Secretary – Support for say-on-pay votes continues to erode in US, warn compensation advisers
While investors are increasing their scrutiny of executive compensation packages again this year, the pandemic may not be playing a meaningful role, according to executive compensation experts.
Read MoreMay 11, 2021
Agenda – In a SPAC-Driven World, How Much Is a Board Seat Worth?
By Robin Ferracone, Angela Moe
Read MoreMay 10, 2021
Bloomberg – CEO Pandemic Pay: ‘Heads I Win, Tails I Win Almost as Much’
Norwegian Cruise Line called 2020 its “most challenging year.” The company lost $4 billion, a half decade’s worth of profit. Shares dropped 56%. Thousands of crew members lost their livelihoods.
Read More